Chris D Schubart
Overview
Explore the profile of Chris D Schubart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marchi M, Elkrief L, Alkema A, van Gastel W, Schubart C, van Eijk K, et al.
Transl Psychiatry
. 2022 Jun;
12(1):219.
PMID: 35650188
Childhood maltreatment (CM) and genetic vulnerability are both risk factors for psychosis, but the relations between them are not fully understood. Guided by the recent identification of genetic risk to...
2.
Deijns S, Broen J, Kruyt N, Schubart C, Andreoli L, Tincani A, et al.
Autoimmun Rev
. 2020 Jun;
19(8):102592.
PMID: 32561462
Introduction: The aim of this narrative review is to provide an overview of the literature on the possible immunologic pathophysiology of psychiatric manifestations of neuropsychiatric systemic lupus erythematosus (NPSLE). Methods:...
3.
Boks M, He Y, Schubart C, van Gastel W, Elkrief L, Huguet G, et al.
Brain Behav Immun
. 2020 Apr;
88:573-581.
PMID: 32330591
To investigate the biological mechanisms underlying the higher risk for psychosis in those that use cannabis, we conducted a genome-wide environment-interaction study (GWEIS). In a sample of individuals without a...
4.
Bossong M, van Hell H, Schubart C, van Saane W, Iseger T, Jager G, et al.
Eur Neuropsychopharmacol
. 2019 Apr;
29(6):766-776.
PMID: 30975584
Cannabis produces a broad range of acute, dose-dependent psychotropic effects. Only a limited number of neuroimaging studies have mapped these effects by examining the impact of cannabis on resting state...
5.
He Y, de Witte L, Schubart C, Van Gastel W, Koeleman B, de Jong S, et al.
Eur Neuropsychopharmacol
. 2019 Mar;
29(5):643-652.
PMID: 30879928
The relation of heavy cannabis use with decreased neuropsychological function has frequently been described but the underlying biological mechanisms are still largely unknown. This study investigates the relation of cannabis...
6.
Leentjens A, van Baalen A, Kuijpers H, Lambooij S, Schubart C, Sno H, et al.
J Psychosom Res
. 2018 May;
110:12-14.
PMID: 29764599
No abstract available.
7.
Bakker I, Schubart C, Zelissen P
Endocrinol Diabetes Metab Case Rep
. 2016 Jun;
2016:160028.
PMID: 27284453
Unlabelled: In this report, we describe a female patient with both prolactinoma and psychotic disorder who was successfully treated with aripiprazole, a partial dopamine 2 receptor agonist. During the follow-up...
8.
Vleeschouwer M, Schubart C, Henquet C, Myin-Germeys I, Van Gastel W, Hillegers M, et al.
PLoS One
. 2014 Jan;
9(1):e84011.
PMID: 24465389
Background: The psychometric properties of an online test are not necessarily identical to its paper and pencil original. The aim of this study is to test whether the factor structure...
9.
de Jong S, Boks M, Fuller T, Strengman E, Janson E, de Kovel C, et al.
PLoS One
. 2012 Jul;
7(6):e39498.
PMID: 22761806
Despite large-scale genome-wide association studies (GWAS), the underlying genes for schizophrenia are largely unknown. Additional approaches are therefore required to identify the genetic background of this disorder. Here we report...
10.
Wijkstra J, Schubart C, Nolen W
World J Biol Psychiatry
. 2007 Oct;
10(4 Pt 2):409-15.
PMID: 17963187
Introduction: In a recent meta-analysis we found no evidence that an antidepressant plus an antipsychotic is more effective than an antidepressant alone in unipolar psychotic depression. However, most current guidelines...